Skip to main content
. 2021 Apr 22;9:636136. doi: 10.3389/fcell.2021.636136

FIGURE 1.

FIGURE 1

The current dilemma with stem cell therapy in ischemic heart disease (IHD). MSC, Mesenchymal stem cell; iPSC, induced pluripotent stem cell; ESC, embryonic stem cell; EPC, endothelial progenitor cell; HSC, hematopoietic stem cell; BMMNC, bone marrow-derived mononuclear cell.